日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2015/09/04 | 日証協 | 680,255株 | +5.77% | 882,632株 | +186.25% | 690,510株 | +40.48% | 442,348株 | +171.02% |
2015/08/28 | 日証協 | 643,136株 | +8.71% | 308,346株 | -39.43% | 491,527株 | +18.09% | 163,216株 | -9.77% |
2015/08/21 | 日証協 | 591,588株 | +21.17% | 509,045株 | +24.32% | 416,248株 | +45.41% | 180,896株 | +2.2% |
2015/08/14 | 日証協 | 488,243株 | -1.6% | 409,452株 | +43.76% | 286,260株 | +3.54% | 177,000株 | +221.86% |
2015/08/07 | 日証協 | 496,204株 | -8.88% | 284,807株 | +29.91% | 276,468株 | -12.86% | 54,993株 | -47.94% |
2015/07/31 | 日証協 | 544,561株 | -3.93% | 219,233株 | -6.92% | 317,266株 | -0.18% | 105,638株 | +57.67% |
2015/07/24 | 日証協 | 566,813株 | -7.29% | 235,534株 | -44.58% | 317,837株 | -7.12% | 67,000株 | -59.25% |
2015/07/17 | 日証協 | 611,354株 | +14.24% | 424,965株 | -24.96% | 342,214株 | -10.7% | 164,413株 | -43.18% |
2015/07/10 | 日証協 | 535,167株 | -3.77% | 566,310株 | +26.03% | 383,214株 | +45.47% | 289,379株 | +85.98% |
2015/07/03 | 日証協 | 556,124株 | +80.25% | 449,363株 | +156.73% | 263,431株 | +63.11% | 155,596株 | +412.22% |
2015/06/26 | 日証協 | 308,526株 | -1.27% | 175,033株 | -14.99% | 161,502株 | -18.31% | 30,377株 | +15.16% |
2015/06/19 | 日証協 | 312,497株 | +31.15% | 205,908株 | +657.07% | 197,709株 | -3.61% | 26,377株 | -24.64% |
2015/06/12 | 日証協 | 238,283株 | +15.1% | 27,198株 | -78.19% | 205,112株 | +11.54% | 35,000株 | -49.84% |
2015/06/05 | 日証協 | 207,014株 | -20.7% | 124,731株 | -56.21% | 183,883株 | -24.11% | 69,781株 | -34.02% |
2015/05/29 | 日証協 | 261,053株 | 0% | 284,819株 | 0% | 242,314株 | 0% | 105,757株 | 0% |
2015/05/15 | 日証協 | 304,489株 | -3.53% | 144,052株 | +112.11% | 327,661株 | -7.1% | 65,460株 | +48.48% |
2015/05/08 | 日証協 | 315,618株 | +0.29% | 67,913株 | +1258.26% | 352,714株 | -4.34% | 44,087株 | +127.58% |
2015/05/01 | 日証協 | 314,705株 | -4.26% | 5,000株 | -84.85% | 368,714株 | -3.43% | 19,372株 | +1.96% |
2015/04/24 | 日証協 | 328,705株 | -13.23% | 33,000株 | -10.81% | 381,794株 | -4.98% | 19,000株 | -24% |
※株式分割は考慮していませんのでご注意ください。
Page Top